María Ángeles Onieva-García

Dr. María Ángeles Onieva-García

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2016 in Injury Epidemiology
Verified
Journal Article
Open access
PDF file
MOMaría Ángeles Onieva-García
María Ángeles Onieva-García
VMVirginia Martínez-Ruiz
Virginia Martínez-Ruiz
PLPablo Lardelli-Claret
Pablo Lardelli-Claret
JJJose J. Jimenez-Moleon
Jose J. Jimenez-Moleon
CACarmen Amezcua-Prieto
Carmen Amezcua-Prieto
EJEladio Jiménez-Mejías
Eladio Jiménez-Mejías
This ecological study aimed i) to quantify the association of age and gender with the three components of pedestrians’ death rates after a pedestrian-vehicle crash: exposure, risk of crash and fatality, and ii) to determine the contribution of each component to differences in death rates according to age and gender in Spain. We analyzed data for 220 665 pedestrians involved in road crashes recorded in the Spanish registry of road crashes with victims from 1993 to 2011, and a subset of 39 743 pedestrians involved in clean collisions (in which the pedestrian did not commit an infraction). Using decomposition and quasi-induced exposure methods, we obtained the proportion of increase in death rates for each age and gender group associated with exposure, risk of collision and fatality. Death rates increased with age. The main contributor to this increase was fatality, although exposure also increased with age. In contrast, the risk of collision decreased with age. Males had higher death rates than females, especially in the 24–54 year old group. Higher fatality rates in males were the main determinant of this difference, which was also related with a higher risk of collision in males. However, exposure rates were higher in females. The magnitude and direction of the associations between age and gender and each of the three components of pedestrians’ death rates differed depending on the specific component explored. These differences need to be taken into account in order to prioritize preventive strategies intended to decrease mortality among pedestrians.

10 January 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
EREsther Redondo-Margüello
Esther Redondo-Margüello
IRIrene Rivero-Calle
Irene Rivero-Calle
EMEnrique Mascarós
Enrique Mascarós
DODaniel Ocaña
Daniel Ocaña
IJIsabel Jimeno
Isabel Jimeno
Federico Martinón-TorresFederico Martinón-Torres
Federico Martinón-Torres
In the adult population, community-acquired pneumonia (CAP) is a serious disease that is responsible for high morbidity and mortality rates, being frequently associated with multidrug resistant pathogens. The aim of this review is to update a practical immunization prevention guideline for CAP in Spain caused by prevalent respiratory pathogens, based on the available scientific evidence through extensive bibliographic review and expert opinion. The emergence of COVID-19 as an additional etiological cause of CAP, together with the rapid changes in the availability of vaccines and recommendations against SARS-CoV-2, justifies the need for an update. In addition, new conjugate vaccines of broader spectrum against pneumococcus, existing vaccines targeting influenza and pertussis or upcoming vaccines against respiratory syncytial virus (RSV) will be very useful prophylactic tools to diminish the burden of CAP and all of its derived complications. In this manuscript, we provide practical recommendations for adult vaccination against the pathogens mentioned above, including their contribution against antibiotic resistance. This guide is intended for the individual perspective of protection and not for vaccination policies, as we do not pretend to interfere with the official recommendations of any country. The use of vaccines is a realistic approach to fight these infections and ameliorate the impact of antimicrobial resistance. All of the recently available scientific evidence included in this review gives support to the indications established in this practical guide to reinforce the dissemination and implementation of these recommendations in routine clinical practice.

1 March 2015 in Fertility and Sterility
Verified
Journal Article
Closed access
ETElisa Hernandez Torres
Elisa Hernandez Torres
JNJosé Luis Navarro-Espigares
José Luis Navarro-Espigares
ACAna Clavero
Ana Clavero
MLMaLuisa López-Regalado
MaLuisa López-Regalado
JCJosé A. Camacho-Ballesta
José A. Camacho-Ballesta
JCJose Antonio Castilla
Jose Antonio Castilla

2 October 2015 in Revista Clínica Española
Verified
Journal Article
Closed access
MOMaría Ángeles Onieva-García
María Ángeles Onieva-García
ALA. Llanos-Méndez
A. Llanos-Méndez
EBE. Baños-Álvarez
E. Baños-Álvarez
RIR. Isabel-Gómez
R. Isabel-Gómez

21 July 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
MEMónica Espinar-García
Mónica Espinar-García
IBIsabel María Vallejo Bermúdez
Isabel María Vallejo Bermúdez
MOMaría Ángeles Onieva-García
María Ángeles Onieva-García
EAEster Irene Reina Alfonso
Ester Irene Reina Alfonso
LLLuis Llapa-Chino
Luis Llapa-Chino
Alexander Batista DuharteAlexander Batista Duharte
Alexander Batista Duharte
Background: Annual influenza vaccine updates target viral drift, but immune responses may be biased by original antigenic sin (OAS). Few studies have explored this across closely related strains. This study examines how OAS shapes responses to sequential influenza variants in the context of seasonal vaccination. Methods: We conducted a prospective, longitudinal study to assess the humoral immune response to the 2023–2024 seasonal influenza vaccine containing the A/Victoria/4897/2022 (H1N1) strain. Bioinformatic analyses compared the hemagglutinin (HA) sequences of A/Victoria/4897/2022 and the antigenically related A/Victoria/2570/2019 strain. B-cell epitopes were mapped with BepiPred-3.0 and BepiBlast, and their physicochemical properties analyzed via accessibility, β-turns, flexibility, and hydrophilicity. Antibody responses were measured pre- and 28 days post-Vaxigrip Tetra vaccination in young (18–35) and older (>65) adults, stratified by cytomegalovirus (CMV) serostatus. HA sequences showed >97% identity, with variations mainly in the globular head. Predicted B-cell epitopes overlapped variable sites, suggesting possible immune escape. Despite having been vaccinated against the 2022 strain, serology showed higher antibody titers against the 2019 HA strain in all participants. This pattern suggests a potential antigen imprinting effect, though confirmation awaits further analysis. Age groups differed: older adults showed greater variability, while younger CMV+ individuals tended toward stronger 2019 HA responses. Conclusions: These findings suggest a complex interplay of factors shaping immune responses, though the imprinting effect and the potential role of CMV warrant further exploration in larger, more focused studies.

1 October 2015 in Revista Espanola de Salud Publica
Verified
Journal Article
Open access
PDF file
MOMaría Ángeles Onieva-García
María Ángeles Onieva-García
BLBegoña López-Hernández
Begoña López-Hernández
MMMaría José Molina-Rueda
María José Molina-Rueda
NCNatalia Cabrera-Castro
Natalia Cabrera-Castro
MMMaría del Mar Mochón-Ochoa
María del Mar Mochón-Ochoa
In 2009 a system was introduced for the automatic import (AI) of cases with suspected notifiable diseases (ND) from electronic medical record (EMR) to RedAlerta, an application for surveillance in Andalusia. At present, the contribution of this system to classical active statement has not been determined enough. The main objective of this study is to evaluate the usefulness of IA in the province of Granada, between 2009 and 2014. During the study period (2009-2014), an epidemiologist assessed whether AI met declaration criteria or not. We calculate the contribution of AI to RedAlerta and the percentage of validation of AI, estimating 95% CI. The contribution of AI was 17.3% (95% CI 16.1 to 18.5); and type of statement, 5.2% (95% CI 4.1 to 6.5) for urgent and 24.4% (95% CI 22.7 to 26.2) for ordinary. The contribution was higher (more than 45%) in Lyme disease, congenital hypothyroidism, genital herpes, hepatitis C and other viral hepatitis. 30% (95% CI 28.1 to 32) of AI were validated; 39.9% (95% CI 33 to 47.2) urgent and 29.1% (95% CI 27.2 to 31.2%) ordinary. The percentage of validation was higher than 45% (between 47.5 and 100%) in vaccine-preventable diseases, sexually transmitted infections and low incidence. Although not replace manual reporting and requires verification, the AI system is useful and increases the completeness of the epidemiological surveillance system.